Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Nutriband Inc
NTRB | US
4.01
USD-0.16
-3.84%
NTRB | US
Loading StockChartView...
About Nutriband Inc
Sector
Healthcare
Industry
Medical Instruments & Supplies
Earnings date
31/07/2024
As of date
23/04/2026
Close
4.01
Open
4.13
High
4.13
Low
3.95
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando Florida.
View LessNTRB | US
Risk
54.5
Sharpe
-0.32
Luna's Score
43/100
Recommendation
Sell
Luna says (NTRB | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
38.8%1 month
54.5%3 months
55.5%6 months
68.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
370.37
Price to book
5.83
Debt to equity
0.02
Debt to assets
0.02
Ent. to EBITDA
-4.55
Ent. to rev.
36.66
PEG
-
Other Fundamentals
EBITDA
-5.46M
MarketCap
44.50M
MarketCap(USD)
44.50M
Div. yield
-
Op. margin
-462.50
Erngs. growth
-
Rev. growth
-14.30
Ret. on equity
-60.41
Short ratio
1.53
Short perc.
1.00
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.58
Range1M
0.85
Range3M
1.56
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.96
Price X volume
29.69K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.55 | 4.19 | Cheaper |
| Ent. to Revenue | 36.66 | 8.10 | Expensive |
| PE Ratio | - | 47.18 | - |
| Price to Book | 5.83 | 5.71 | Par |
| Dividend Yield | - | 1.35 | - |
| Std. Deviation (3M) | 55.53 | 56.96 | Par |
| Debt to Equity | 0.02 | 0.92 | Cheaper |
| Debt to Assets | 0.02 | 0.27 | Cheaper |
| Market Cap | 44.50M | 10.37B | Emerging |
